United States Antimony Corporation filings document the public-company record for an antimony, zeolite and critical-minerals producer and processor. Recent 8-K reports cover operating and financial results, conference-call materials, officer and finance-leadership changes, and operational updates tied to the Fostung tungsten property and its Technical Report Summary.
The company’s proxy materials describe annual-meeting voting matters and shareholder governance procedures. Its Form 25 records the withdrawal of common stock from NYSE American following the completed transfer of the listing to the New York Stock Exchange, while later current reports identify UAMY common stock as listed on the NYSE and NYSE Texas. The filings also disclose the company’s common stock class, par value, reporting status, and material-event exhibits.
UNITED STATES ANTIMONY CORP director Blaise A. Aguirre reported multiple dispositions of common stock back to the company. On March 31, 2026, he disposed of several blocks totaling 27,000 shares at prices between $8.20 and $8.26 per share, each coded as a “Disposition to issuer” (D). After these transactions, he directly held 845,754 shares of United States Antimony common stock.
UNITED STATES ANTIMONY CORP director and executive officer Lloyd Bardswich reported two dispositions of common stock back to the issuer. On March 26, 2026, he disposed of 46,674 shares at $9.34 per share, and on March 27, 2026, he disposed of 36,181 shares at $9.05 per share.
Across both transactions, a total of 82,855 common shares were returned to the company. Following these issuer dispositions, Bardswich directly holds 937,355 shares of UNITED STATES ANTIMONY CORP common stock, indicating he retains a substantial equity position after the reported activity.
UNITED STATES ANTIMONY CORP director Blaise A. Aguirre reported returning shares of common stock to the company. On March 24, 2026, he disposed of 20,000 shares at $9.16 per share, a transaction classified as a "Disposition to issuer".
On March 27, 2026, he reported two additional dispositions to the issuer of 6,339 shares at $8.78 per share and 5,373 shares at $8.77 per share. After these transactions, he directly held 872,754 shares of common stock, indicating that only a small portion of his overall position was returned to the company.
UNITED STATES ANTIMONY CORP granted equity awards to Chairman & CEO Gary C. Evans as part of compensation. He received a time-based restricted stock unit (RSU) award covering 304,524 shares of Common Stock under the Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares, vest on January 15, 2026, with additional one-third portions vesting on January 15, 2027 and January 18, 2028, subject to continued service. He also received a stock option for 308,133 shares of Common Stock with a conversion or exercise price of $8.29 per share, which can vest upon meeting specified performance measures at any time during its 10-year term, also contingent on continued service. These are grant/award acquisitions, not open-market purchases or sales.
United States Antimony Corp granted equity awards to John C. Gustavsen, its President, Antimony Division. He received a restricted stock unit award covering 50,754 shares of Common Stock, vesting in three equal installments on January 15, 2026, January 15, 2027, and January 18, 2028, subject to continued service. He was also granted a stock option over 61.627 shares of Common Stock at an exercise price of $8.2900 per share, which vests upon achieving specified performance measures at any time during its 10-year term, also conditioned on continued service. These are compensation-related grants, not open-market purchases or sales.
United States Antimony Corp Schedule 13G/A: The Vanguard Group reports 0 shares beneficially owned, representing 0% of the common stock. The amendment explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538, causing certain Vanguard subsidiaries or business divisions to report separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
UNITED STATES ANTIMONY CORP reported an insider transaction by its SVP and Chief Financial Officer, Richard R. Isaak. He disposed of a total of 83,334 shares of common stock back to the company in two issuer-related transactions, not open-market sales.
On March 25, he returned 30,000 shares at $10.00 per share, and on March 26, he returned 53,334 shares at $9.00 per share. Following these transactions, he directly holds 354,886 shares of common stock.
United States Antimony Corp Chairman and CEO Gary C. Evans reported four issuer dispositions of Common Stock on March 25, 2026, totaling 400,000 shares at prices between 9.76 and 9.88 per share. After these transactions, he directly owns 2,231,951 shares.
US Antimony (UAMY) submitted a Form 144 reporting proposed sales of common stock. The filing lists two restricted common share entries of 66,667 shares dated 03/03/2025 and 05/15/2024 and reports 30,000 shares sold during the past three months on 03/25/2026.
The notice names Merrill (address shown) as the broker and indicates the securities trade on the NYSE. The filing is a routine notification of proposed or recent dispositions of restricted common stock.
UAMY proposed multiple open-market sales of Common Stock via Form 144, listing sale blocks on December 6–9 and December 12–13, 2022. The excerpt shows individual proposed sale amounts of 40,000, 251,281, 51,653 and 57,066 shares on those dates.